Home
About
Technology
Team
Pipeline
Publications
News
Careers
Policies
Contact us
Test job
abc
pdx news
PDX Pharma awarded two-year $1.87M phase II SBIR grant from the National Cancer Institute (NCI) for the development of ARAC-02, a novel lung cancer treatment
2/21/2023
read more
PDX Pharma’s ARAC-02 drug candidate has been selected into the Nanotechnology Characterization Lab (NCL)’s collaboration and characterization program.
1/5/2023
read more
PDX Pharma won two Corporate Philanthropy Awards
11/2/2022
read more
Copyright © 2017
PDX Pharmaceuticals
, Inc. All rights reserved